moving the mpn field forward
Published 3 years ago • 37 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
2:06
how the mpn field has evolved over the years: novel agents, trials, and more
-
1:31
novel treatment agents and how they're changing the mpn field
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
2:28
how to approach the treatment of younger patients with mpn
-
0:56
the role of navtemadlin in the mpn treatment landscape
-
1:11
the treatment of aml within the united kingdom nhs framework
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
1:59:56
mmyprespt2hd2024
-
21:15
2023 eurollvm - machinescheduler - fine grain resource allocation using resource intervals.
-
4:00
explaining myeloproliferative neoplasm disease progression to patients
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
1:06
clinical hematology: moving forward
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:32
genomic sequencing as a driver of advancements in pediatric hematology
-
2:08
looking forward to the texas mpn workshop 2020
-
1:26
the future of jak inhibition for mpns
-
2:43
the management of advanced phase mpns
-
1:41
the future of mpn therapy
-
1:13
ongoing trials in wm, where the field is moving, and the growing role of novel agents
-
1:26
what to look forward to from the texas mpn workshop 2020